Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study

M Fareed K Suri1, Kazumasa Yamagishi, Nena Aleksic

  • 1Department of Neurology, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Insights

Higher levels of factor XI, a clotting protein, are linked to an increased risk of ischemic stroke. This finding may help identify individuals at greater risk for stroke.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Epidemiology

Background:

  • The association between hemostatic factor levels and cerebral infarction (ischemic stroke) is not fully understood.
  • Several under-studied hemostatic factors require investigation in relation to stroke risk.

Purpose of the Study:

  • To investigate the association of specific hemostatic factor levels with the incidence of ischemic stroke.
  • To identify potential biomarkers for predicting ischemic stroke risk in a population-based cohort.

Main Methods:

  • Utilized a case-cohort design within the Atherosclerosis Risk in Communities (ARIC) study (n=15,792).
  • Measured levels of hemostatic factors (II, V, IX, X, XI, XII, plasminogen, alpha(2)-antiplasmin) in plasma samples.
  • Employed multivariate proportional hazard regression analyses to assess associations with incident ischemic stroke over a median of 7.5 years.

Main Results:

  • Elevated levels of factor XI, factor IX, and alpha(2)-antiplasmin were initially associated with increased ischemic stroke risk (highest vs. lowest quartiles).
  • After multivariate adjustment, only higher factor XI levels remained significantly associated with an increased risk of ischemic stroke (HR 1.50, 95% CI 1.10-2.05).

Conclusions:

  • Increased levels of factor XI are associated with a higher risk of developing ischemic stroke.
  • Factor XI may serve as a valuable biomarker for identifying individuals at elevated risk of ischemic stroke.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.